Rxsight Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.0% | -34.6% | -31.5% | -11.8% | 1.6% | -10.6% | -23.3% | -13.0% | -3.9% | -3.4% | -35.3% | -28.3% | -17.8% | |
| 3.7% | 3.8% | 3.9% | 2.4% | 2.5% | 1.3% | 2.1% | 2.3% | 2.8% | 2.6% | 2.7% | 3.0% | 2.8% | |
| 13.3% | 15.5% | 15.9% | 17.5% | 14.4% | 18.1% | 18.8% | 25.4% | 26.7% | 24.0% | 25.7% | 22.1% | 24.6% | |
| -1.9% | -11.2% | -15.8% | -8.2% | 4.1% | -8.9% | -16.4% | -3.0% | 5.8% | 1.8% | -6.4% | -16.2% | -4.0% | |
| 2.1% | 5.6% | 6.7% | 4.4% | 2.4% | 2.1% | 1.5% | 4.6% | 1.9% | 3.5% | 2.5% | 5.8% | 3.5% | |
| 56.3% | 16.0% | 82.3% | -331.5% | -20.4% | 3.3% | 55.0% | 43.6% | -29.7% | -29.5% | 28.6% | 13.8% | -4.0% | |
| 3.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3.5% | 0.0% | -7.2% | 0.0% | 4.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -26.8% | 18.0% | 27.1% | 319.8% | 1.8% | 7.4% | -1.9% | 6.1% | -1.7% | 3.3% | -1.1% | 2.0% | 0.7% | |
| 3.4% | -0.6% | 77.8% | -23.5% | -17.0% | 0.0% | 29.8% | 36.7% | -35.3% | -29.7% | -7.7% | -12.5% | -21.2% | |
| -28.2% | -40.2% | -38.2% | -16.1% | -0.8% | -12.7% | -24.8% | -17.6% | -5.8% | -6.9% | -37.7% | -34.1% | -21.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.